✦ LIBER ✦

K-ras and p16INK4Aalterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers

✍ Scribed by Destro, A; Bianchi, P; Alloisio, M; Laghi, L; Di Gioia, S; Malesci, A; Cariboni, U; Gribaudi, G; Bulfamante, G; Marchetti, A; Bosari, S; Infante, M; Ravasi, G; Roncalli, M

Book ID: 119318825
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 323 KB
Volume: 44
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2003.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequencies of p16INK4a promoter hyperme

Frequencies of p16INK4a promoter hypermethylation, p53 and K-ras mutations detectable in exfoliative material differentiate between chronic smokers and lung cancer patients

✍ Kersting, M; Friedl, C; Kraus, A; Behn, M; Kersting, M; Fried, C; Kraus, A; Behn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 202 KB

The possible role of P16/INK4A promoter

The possible role of P16/INK4A promoter methylation and K-ras mutations in the endoscopical diagnosis of bile duct carcinoma

✍ Bodo Klump; Chih-Jen Hsieh; Irena Joleska; Stephan Dette; Marianne Ortner; U. Si 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB

P-278 RASSF1A methylation and k-ras in s

P-278 RASSF1A methylation and k-ras in sputum of patients with lungcarcinoma

✍ Thunnissen, F.; Bolijn, A.; Hol, B.; Prinsen, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

P3.48. No mutations found in the exon 2

P3.48. No mutations found in the exon 2 of p16 INK4a and K-ras genes following rat tongue carcinogenesis induced by 4NQO

✍ Minicucci, E.M.; Silva, G.N.; Ribeiro, D.A.; Salvadori, D.M.F. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 173 KB

P075 - Detection of K-ras and p53 gene m

P075 - Detection of K-ras and p53 gene mutations and hypermethylation of P16 in colonic lavage of patients with chronic inflammatory bowel diseases

✍ A. Breitrueck; M. Krech; S. Liebe; J. Emmrich 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 46 KB

K-ras mutation in sputum of patients wit

K-ras mutation in sputum of patients with or without lung cancer

✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle